Jade Biosciences Announces $135 Million Private Placement
SAN FRANCISCO and VANCOUVER, BC — Jade Biosciences, Inc, a clinical-stage biotechnology company focused on developing best-in-class therapies for autoimmune diseases, announced that it has entered into a securities purchase… Read More



